IADR Abstract Archives

Prevalence and Severity of Dentin Hypersensitivity: a Global Perspective

 

Objectives: To assess the global prevalence and pain severity of dentine hypersensitivity.

 

Methods: Surveys were conducted to ascertain the prevalence of dentine hypersensitivity across the globe, the severity of pain and whether sufferers sought dental advice. A total of 12,205 adults aged 18 years and over, were questioned through omnibus or ad-hoc studies.

 

Results: Prevalence of dentine hypersensitivity was assessed according to geographical location, age group and gender. The results are summarized in Table 1.

 

 

Table 1:

Geographical location

 

% experienced sensitive teeth

% Age group

% Gender

18-24

25-44

45-64

65+

Male

Female

World

(n = 12,205)

45

43

43

45

41

38

48

Europe

(n = 6922)

45

39

42

49

45

39

50

N.America

(n = 2029)

37

44

39

35

31

31

42

Rest of the World

(n = 3254)

52

50

56

54

55

50

54

 

The level of pain severity associated with dentine hypersensitivity reported by individuals in each region, as well as the proportion of sufferers who failed to consult a dentist is given in Table 2.

 

Table 2:

Geographical location

Severity of pain

 

Failed to consult a dentist

Very severe

Fairly severe

Fairly mild

Very mild

World

5%

17%

43%

34%

51%

Europe

4%

20%

50%

26%

47%

N.America

7%

16%

39%

36%

39%

Rest of the World

3%

12%

35%

47%

34%

 

 

Conclusions:

 

  • Dentine hypersensitivity affects more than 40% of the global population, with prevalence higher in women than men.
  • The majority experience mild pain, although a quarter of sufferers in Europe and N.America report severe pain.
  • A high proportion of sufferers do not seek advice. Dental professionals therefore need to proactively screen patients to reduce the number of individuals with dentine hypersensitivity remaining undiagnosed and under-treated.

 

 

 


IADR/PER General Session
2003 IADR/PER General Session (Goteborg, Sweden)
Goteborg, Sweden
2003
970
Behavioral Sciences/Health Services Research
  • Graham, F.l  ( GlaxoSmithKline, Jersey City, NJ, USA )
  • Tatton-brown, C  ( Research Quorum, Basingstoke, N/A, United Kingdom )
  • Meert, G  ( Research Quorum, Basingstoke, N/A, United Kingdom )
  • Alexander, David C  ( GlaxoSmithKline, Jersey City, NJ, USA )
  • Poster
    Prevalence of Oral Health Conditions
    06/26/2003